China Pharma Holdings (CPHI) Notes Payables (2016 - 2025)
Historic Notes Payables for China Pharma Holdings (CPHI) over the last 13 years, with Q3 2025 value amounting to $1.4 million.
- China Pharma Holdings' Notes Payables rose 34807.06% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 34807.06%. This contributed to the annual value of $1.1 million for FY2024, which is 98.57% up from last year.
- China Pharma Holdings' Notes Payables amounted to $1.4 million in Q3 2025, which was up 34807.06% from $1.4 million recorded in Q2 2025.
- China Pharma Holdings' Notes Payables' 5-year high stood at $4.6 million during Q3 2022, with a 5-year trough of $315428.0 in Q3 2024.
- In the last 5 years, China Pharma Holdings' Notes Payables had a median value of $1.3 million in 2021 and averaged $1.7 million.
- Per our database at Business Quant, China Pharma Holdings' Notes Payables plummeted by 8444.44% in 2024 and then soared by 34807.06% in 2025.
- Quarter analysis of 5 years shows China Pharma Holdings' Notes Payables stood at $1.2 million in 2021, then surged by 222.25% to $3.8 million in 2022, then crashed by 70.16% to $1.1 million in 2023, then grew by 0.99% to $1.1 million in 2024, then increased by 23.44% to $1.4 million in 2025.
- Its Notes Payables stands at $1.4 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.2 million for Q1 2025.